SG Americas Securities LLC Makes New $33,000 Investment in Cibus, Inc. (NASDAQ:CBUS)

SG Americas Securities LLC purchased a new stake in Cibus, Inc. (NASDAQ:CBUS) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 10,044 shares of the company’s stock, valued at approximately $33,000.

Other hedge funds have also modified their holdings of the company. Armistice Capital LLC purchased a new stake in Cibus in the 2nd quarter valued at about $5,083,000. Vanguard Group Inc. raised its stake in shares of Cibus by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock valued at $16,215,000 after acquiring an additional 26,017 shares during the period. Rhumbline Advisers purchased a new stake in shares of Cibus in the 2nd quarter valued at approximately $221,000. FineMark National Bank & Trust lifted its holdings in shares of Cibus by 24.3% in the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after acquiring an additional 4,000 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Cibus during the 2nd quarter worth approximately $529,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CBUS. Canaccord Genuity Group reissued a “buy” rating and issued a $20.00 target price on shares of Cibus in a research report on Tuesday, October 22nd. Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a report on Friday, July 19th. Finally, Alliance Global Partners lowered their target price on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a report on Tuesday, September 24th.

Cibus Stock Up 2.7 %

Cibus stock opened at $4.16 on Wednesday. The company’s 50 day moving average is $4.58 and its two-hundred day moving average is $9.48. The firm has a market cap of $89.63 million, a PE ratio of -0.22 and a beta of 1.81. Cibus, Inc. has a 52-week low of $2.86 and a 52-week high of $23.18.

Cibus (NASDAQ:CBUS) last released its earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.33). Cibus had a negative net margin of 9,856.84% and a negative return on equity of 29.05%. The company had revenue of $0.84 million during the quarter, compared to analysts’ expectations of $0.44 million. During the same quarter last year, the business posted ($3.05) earnings per share. On average, equities research analysts anticipate that Cibus, Inc. will post -3.84 earnings per share for the current fiscal year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.